Fast Track designation is granted by regulatory bodies like the FDA in the United States. It is designed to facilitate the development and expedite the review of drugs that treat serious conditions and fill an unmet medical need. This can include faster approval processes, more frequent meetings with the FDA, and eligibility for accelerated approval and priority review.
